Skip to main content
PACIFIC EDGE LIMITED logo

PACIFIC EDGE LIMITED — Investor Relations & Filings

Ticker · PEB ISIN · NZPEBE0002S1 LEI · 9845007EDCF068FFEA12 ASX Professional, scientific and technical activities
Open in API
Filings indexed 755 across all filing types
Latest filing 2017-04-03 Major Shareholding Noti…
Country NZ New Zealand
Listing ASX PEB

About PACIFIC EDGE LIMITED

https://www.pacificedgedx.com/

Pacific Edge Limited is a cancer diagnostics company specializing in the development and commercialization of non-invasive molecular diagnostic tests. The company's primary product suite, Cxbladder, utilizes advanced mRNA biomarker technology to detect and monitor bladder cancer from urine samples. These genomic tests are designed to assist clinicians in the evaluation of patients presenting with hematuria and in the ongoing surveillance of patients previously diagnosed with the disease. By providing high sensitivity and negative predictive value, the Cxbladder suite helps to accurately rule out urothelial carcinoma, potentially reducing the requirement for invasive clinical procedures such as cystoscopy. The company focuses on integrating its diagnostic tools into standard clinical pathways to improve patient outcomes and healthcare efficiency.

Recent filings

Filing Released Lang Actions
SSH Notice – Devon Funds Management Limited
Major Shareholding Notification Classification · 100% confidence The document is a disclosure notice regarding the beginning of a substantial holding in a company's shares, specifically under the Financial Markets Conduct Act 2013. It details the percentage of shares held, the parties involved, and the nature of the holding. This type of document is a notification of a major shareholding change, not a financial report, management announcement, or other filing types. The document length is short and focused solely on shareholding disclosure, matching the definition of Major Shareholding Notification (MRQ).
2017-04-03 English
Notice of Issue of Shares on Exercise of Options
Share Issue/Capital Change Classification · 100% confidence The document is a notice regarding a change in issued capital stock due to the exercise of options, detailing the number of shares issued, issue price, and authority for the issue. It is a formal announcement about share issuance and capital changes, referencing NZX Listing Rule 7.3.6. The document length is short (1338 characters) and contains no financial statements or detailed financial analysis. Therefore, it is not a full financial report but an announcement of a capital change event.
2017-04-03 English
Callaghan Innovation Growth Grant for Pacific Edge
Capital/Financing Update Classification · 95% confidence The document is a company announcement dated 21 March 2017 regarding an additional grant received by Pacific Edge Limited for research and development of cancer diagnostics technology. It describes the grant details, the company's products, and their applications. There are no financial statements, earnings data, or detailed financial analysis present. The content focuses on a funding update related to research grants, which is a form of capital or financing update. It is not an earnings release, annual report, or regulatory filing. The document is longer than 5,000 characters and is a substantive announcement about financing support for R&D, fitting the Capital/Financing Update category.
2017-03-21 English
Significant Increase In Clinical Utility From Use of CXB
Regulatory Filings Classification · 90% confidence The document is a detailed announcement from Pacific Edge Limited about the publication approval of an international clinical study demonstrating the clinical utility of their Cxbladder diagnostic tests. It discusses study results, clinical implications, and product descriptions. There is no presentation of financial data, regulatory filings, or management discussion of financial results. The document is not a financial report, earnings release, or regulatory filing. It is a corporate announcement focused on clinical study results and product validation, which does not fit into the financial or regulatory filing categories. Given the content and nature, the best fitting category is Regulatory Filings (RNS) as a general announcement that does not fit other specific categories.
2017-03-14 English
Cxb Monitor significantly outperforms FDA approved tests
Regulatory Filings Classification · 95% confidence The document is a company announcement dated 6 March 2017, discussing the acceptance of a clinical paper for publication validating the performance of the Cxbladder Monitor test for bladder cancer. It highlights clinical study results, product information, and strategic implications. There are no financial statements, regulatory filings, or detailed financial performance data. The document is promotional and informative about a clinical validation and product adoption, not a financial report or regulatory filing. It is not an earnings release, annual report, or interim report. It is also not a presentation or a call transcript. The document is a company announcement about a clinical study and product validation, which fits best under Regulatory Filings (RNS) as a general announcement that does not fit other categories.
2017-03-05 English
SSH – Salt Funds Management Limited
Major Shareholding Notification Classification · 100% confidence The document is a disclosure of a movement of 1% or more in substantial holding or change in nature of relevant interest under the Financial Markets Conduct Act 2013. It details the changes in shareholding percentages, transactions, and relevant dates. It is a notification about changes in significant share ownership levels, specifically a substantial holding notification. It is not an annual report, earnings release, or any other financial report type. The document length is 3374 characters, which is typical for such notifications. Therefore, the appropriate classification is Major Shareholding Notification (MRQ).
2017-02-20 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.